Literature DB >> 16615002

Successful treatment of Helicobacter pylori-negative gastric MALT lymphoma with rituximab.

Nadeem Chaudhary1, Howard Ozer, David Huard, Stan Lightfoot, Sikandar Mesiya.   

Abstract

Helicobacter pylori infection is strongly associated with low-grade gastric lymphoma, commonly known as mucosa-associated lymphoid tissue (MALT) lymphoma. H. pylori eradication leads to complete remission in 80% of early stage MALT lymphomas. The treatment for early stage H. pylori-negative gastric MALT lymphoma is evolving. Rituximab, a chimeric anti-CD20 antibody, has shown response rates of approximately 50% with minimal toxicity in patients with B-cell non-Hodgkin lymphoma. We describe herein the clinical, endoscopic, and histologic features of a patient with H. pylori-negative gastric MALT lymphoma treated successfully with rituximab.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16615002     DOI： 10.1007/s10620-006-3205-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  15 in total

1.  Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma.

Authors:  M Kocher; R P Müller; D Ross; A Hoederath; H Sack
Journal:  Radiother Oncol       Date:  1997-01       Impact factor: 6.280

2.  Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.

Authors:  Giovanni Martinelli; Daniele Laszlo; Andrés J M Ferreri; Giancarlo Pruneri; Maurilio Ponzoni; Annarita Conconi; Cristiano Crosta; Ennio Pedrinis; Francesco Bertoni; Liliana Calabrese; Emanuele Zucca
Journal:  J Clin Oncol       Date:  2005-01-24       Impact factor: 44.544

Review 3.  Immunologic aspects of Helicobacter pylori infection and malignant transformation of B cells.

Authors:  J E Crabtree; J Spencer
Journal:  Semin Gastrointest Dis       Date:  1996-01

4.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.

Authors:  A C Wotherspoon; C Ortiz-Hidalgo; M R Falzon; P G Isaacson
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

5.  Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression.

Authors:  P Hammel; C Haioun; M T Chaumette; P Gaulard; M Divine; F Reyes; J C Delchier
Journal:  J Clin Oncol       Date:  1995-10       Impact factor: 44.544

6.  Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.

Authors:  Annarita Conconi; Giovanni Martinelli; Catherine Thiéblemont; Andrés J M Ferreri; Liliana Devizzi; Fedro Peccatori; Maurilio Ponzoni; Ennio Pedrinis; Stefania Dell'Oro; Giancarlo Pruneri; Virginio Filipazzi; Pierre-Yves Dietrich; Alessandro M Gianni; Bertrand Coiffier; Franco Cavalli; Emanuele Zucca
Journal:  Blood       Date:  2003-07-03       Impact factor: 22.113

7.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

Authors:  A C Wotherspoon; C Doglioni; T C Diss; L Pan; A Moschini; M de Boni; P G Isaacson
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

8.  Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.

Authors:  Holger Nückel; Daniel Meller; Klaus-Peter Steuhl; Ulrich Dührsen
Journal:  Eur J Haematol       Date:  2004-10       Impact factor: 2.997

9.  Rituximab-induced remission of a gastric MALT lymphoma.

Authors:  Yvonne H Datta; Bal Kampalath; David G Binion
Journal:  Leuk Lymphoma       Date:  2004-06

Review 10.  Gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Asyia Ahmad; Yogesh Govil; Barbara B Frank
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864
View more
  3 in total

Review 1.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

2.  Successful treatment of mucosa-associated lymphoid tissue lymphoma in a patient with gastric and rectal lesions with metachronous and ectopic development.

Authors:  Takuya Watanabe; Takeyasu Suda; Haruka Hirono; Katsuhiko Hasegawa; Kenji Soga; Koichi Shibasaki; Hajime Umezu
Journal:  Rare Tumors       Date:  2011-04-04

Review 3.  Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma.

Authors:  Magdalena Witkowska; Piotr Smolewski
Journal:  Mediators Inflamm       Date:  2013-03-28       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.